Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Freidlin

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Biometrics|April 25, 2001
Unconditional versions of several tests commonly used in the analysis of contingency tablesB Freidlin
Annals of Human Genetics|April 3, 2001
On power and efficiency robust linkage tests for affected sibsJ L Gastwirth, B Freidlin
British Journal of Cancer|May 13, 2015
Response to comment on: 'evaluation of chemoresponse assays as predictive biomarkers'E L Korn, B Freidlin
Bone Marrow Transplantation|June 1, 2011
Assessing causal relationships between treatments and clinical outcomes: always read the fine printB Freidlin, E L Korn
British Journal of Cancer|January 14, 2015
Evaluation of chemoresponse assays as predictive markersE L Korn, B Freidlin
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2017
Interim monitoring for non-inferiority trials: minimizing patient exposure to inferior therapiesE L Korn, B Freidlin
Annals of Human Genetics|August 14, 2002
Robust TDT-type candidate-gene association testsG Zheng, B Freidlin, J L Gastwirth
Controlled Clinical Trials|September 30, 1999
Data monitoring committees and interim monitoring guidelinesB Freidlin, E L Korn, S L George
Biometrics|April 21, 2001
Efficiency robust tests for survival or ordered categorical dataB Freidlin, M J Podgor, J L Gastwirth
Cancer Treatment and Research|January 1, 1995
A Bayesian model for evaluating specificity of treatment effects in clinical trialsR M Simon, D O Dixon, B Freidlin
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Biometrics|April 25, 2001
Unconditional versions of several tests commonly used in the analysis of contingency tablesB Freidlin
Annals of Human Genetics|April 3, 2001
On power and efficiency robust linkage tests for affected sibsJ L Gastwirth, B Freidlin
British Journal of Cancer|May 13, 2015
Response to comment on: 'evaluation of chemoresponse assays as predictive biomarkers'E L Korn, B Freidlin
Bone Marrow Transplantation|June 1, 2011
Assessing causal relationships between treatments and clinical outcomes: always read the fine printB Freidlin, E L Korn
British Journal of Cancer|January 14, 2015
Evaluation of chemoresponse assays as predictive markersE L Korn, B Freidlin
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2017
Interim monitoring for non-inferiority trials: minimizing patient exposure to inferior therapiesE L Korn, B Freidlin
Annals of Human Genetics|August 14, 2002
Robust TDT-type candidate-gene association testsG Zheng, B Freidlin, J L Gastwirth
Controlled Clinical Trials|September 30, 1999
Data monitoring committees and interim monitoring guidelinesB Freidlin, E L Korn, S L George
Biometrics|April 21, 2001
Efficiency robust tests for survival or ordered categorical dataB Freidlin, M J Podgor, J L Gastwirth
Cancer Treatment and Research|January 1, 1995
A Bayesian model for evaluating specificity of treatment effects in clinical trialsR M Simon, D O Dixon, B Freidlin
Pageof 3